GRACEcast - LCVL - What is the best first line treatment for patients with advanced EGFR mutation-positive NSCLC today episode artwork

EPISODE · Dec 9, 2020 · 6 MIN

GRACEcast - LCVL - What is the best first line treatment for patients with advanced EGFR mutation-positive NSCLC today

from GRACEcast - Discussions with the Global Resource for Advancing Cancer Education · host cancerGRACE

Dr. Jonathan Reiss discusses EGFR Mutation and the best first line treatment for patients with advanced EGFR mutation-positive NSCLC today

Episode metadata supplied by the publisher feed · Published Dec 9, 2020

Embed this episode

NOW PLAYING

GRACEcast - LCVL - What is the best first line treatment for patients with advanced EGFR mutation-positive NSCLC today

0:00 6:31

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of GRACEcast - Discussions with the Global Resource for Advancing Cancer Education?

This episode is 6 minutes long.

When was this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode published?

This episode was published on December 9, 2020.

Can I download this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!